FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Concord Biotech IPO and Vishnu Prakash R Punglia IPO.
Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Vishnu Prakash R Punglia IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited |
Choice Capital Advisors Pvt Ltd Pantomath Capital Advisors Pvt Ltd |
Registrar | Link Intime India Private Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | Anchor Investor |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Vishnu Prakash R Punglia IPO is up to ₹308.88 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Vishnu Prakash R Punglia IPO is ₹99.00 per share.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |
---|---|---|
Face Value | ₹1 per share | ₹10 per share |
Issue Price (Lower) | ₹705.00 per share | ₹94.00 per share |
Issue Price (Upper) | ₹741.00 per share | ₹99.00 per share |
Issue Price (Final) | ₹741.00 per share | ₹99.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹70.00 per share | ₹9.00 per share |
Market Lot Size | 20 shares | 150 shares |
Fresh Issue Size | 3,12,00,000 shares | |
Fresh Issue Size (Amount) | ||
OFS Issue Size | 2,09,25,652 shares | |
OFS Issue Size (Amount) | up to ₹1,551.00 Cr | |
Issue Size Total | 2,09,25,652 shares | 3,12,00,000 shares |
Issue Size Total (Amount) | up to ₹1,551.00 Cr | up to ₹308.88 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Vishnu Prakash R Punglia IPO opens on Aug 24, 2023. The closing date of Concord Biotech IPO and Vishnu Prakash R Punglia IPO is Aug 08, 2023, and Aug 28, 2023, respectively.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |
---|---|---|
Anchor Bid Date | Aug 03, 2023 | Aug 23, 2023 |
Issue Open | Aug 04, 2023 | Aug 24, 2023 |
Issue Close | Aug 08, 2023 | Aug 28, 2023 |
Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 31, 2023 |
Initiation of Refunds (Tentative) | Aug 14, 2023 | Sep 01, 2023 |
Credit of Share (Tentative) | Aug 17, 2023 | Sep 04, 2023 |
Listing date (Tentative) | Aug 18, 2023 | Sep 05, 2023 |
Anchor Lockin End date 1 | Sep 10, 2023 | Sep 30, 2023 |
Anchor Lockin End date 2 | Nov 09, 2023 | Nov 29, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Vishnu Prakash R Punglia IPO P/E ratio of 13.61.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Crore |
Amount in ₹ Crore |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 44.08% | 90.45% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 44.08% | 67.81% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 32.29 | 13.61 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹7752.06 Cr. | ₹1234.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 20.06%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 24.27%% | 33.72%% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹20.79 | ₹10.41 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 20%% | 38.31%% |
In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Vishnu Prakash R Punglia IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 61,80,000 shares in Vishnu Prakash R Punglia IPO.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |
---|---|---|
Anchor Investor Reserveration | 62,74,695 shares | 92,70,000 shares |
Market Maker Reserveration | ||
QIB | 41,83,130 shares | 61,80,000 shares |
NII | 31,37,348 shares | 46,35,000 shares |
RII | 73,20,479 shares | 1,08,15,000 shares |
Employee | 10,000 shares | 3,00,000 shares |
Others | ||
Total | 1,46,50,957 shares | 2,19,30,000 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Vishnu Prakash R Punglia IPO subscribed 87.82x.
Concord Biotech IPO | Vishnu Prakash R Punglia IPO | |
---|---|---|
QIB (times) | 67.67x | 171.69x |
NII (times) | 16.99x | 111.03x |
Big NII (times) | 19.30x | 112.02x |
Small NII (times) | 12.37x | 109.07x |
RII (times) | 3.78x | 32.01x |
Employee (times) | 24.48x | 12.97x |
Other (times) | ||
Total (times) | 24.87x | 87.82x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|